Press Releases

Press Releases
Date Title and Summary View
Nov 4, 2009 Newton, MA (November 4, 2009) Pro-Pharmaceuticals, Inc. (OTCBB: PRWP) (the “Company”), today announced that it has closed a $310,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date fr...
Oct 6, 2009 Newton, MA (October 6, 2009) Pro-Pharmaceuticals, Inc. (OTCBB: PRWP) (the “Company”), today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date to ...
Sep 24, 2009 Newton, Mass. (September 24, 2009) Pro-Pharmaceuticals, Inc. (OTC: PRWP) today announced that Theodore Zucconi, Ph.D., Chief Executive Officer, and James Czirr, Chairman of the Board, Pro-Pharmaceuticals, Inc., are scheduled to present a corporate update at the Maxim Group Growth Conference on September 29, 2009 at 4:00 p.m. at the Grand Hyatt H...
Aug 26, 2009 Newton, Mass. (August 26, 2009) Pro-Pharmaceuticals, Inc. (OTC: PRWP) today announced that Theodore Zucconi, Ph.D., Chief Executive Officer, and James Czirr, Chairman of the Board, Pro-Pharmaceuticals, Inc., are scheduled to present a corporate update at the Rodman & Renshaw Annual Global Investment Conference on September 11, 2009 at 3:15 pm at Th...
Aug 24, 2009 Newton, MA – August 24, 2009 – Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancer and fibrosis, today announced the appointment of Arthur R. “Bobby” Greenberg to its Board of Directors. Mr. Greenberg’s appointment brings the Board to nine members....
Aug 14, 2009 Newton, MA – August 24, 2009 – Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancer and fibrosis, today announced the appointment of Arthur R. “Bobby” Greenberg to its Board of Directors. Mr. Greenberg’s appointment brings the Board to nine members....
Jul 23, 2009 Newton, MA, July 23, 2009 – Pro-Pharmaceuticals, Inc. (OTCBB: PRWP) (“the Company”), today announced that the Superior Court of Suffolk County in Massachusetts formally issued its judgment yesterday dismissing the trade secret lawsuit prosecuted by Prospect Therapeutics, Inc. (“Prospect”) against the Company and its f...
Jul 17, 2009 Newton, MA – July 17, 2009 – Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based, targeted therapeutic compounds to treat cancer and fibrosis, today announced that the Suffolk County Superior Court allowed Pro-Pharmaceuticals’ (“the Company”) motion to dismiss the trade secret lawsuit prosecuted ...
Jul 14, 2009 Newton, MA – July 14, 2009 – Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancers and fibrosis, today named Dr. Gilbert S. Omenn to its Scientific Advisory Board. “My research in cancer biology and chemoprevention piqued my interests in P...
Jul 6, 2009 Newton, MA (July 6, 2009) Pro-Pharmaceuticals, Inc. (OTCBB: PRWP) (the “Company”), today announced that it has closed a $500,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date to $3....
FirstPrevious ...
23
NextLast
Add to Briefcase = add release to Briefcase